There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...
Sinusitis can cause facial pressure, sinus headache, and other symptoms. Treatment may depend on the cause. A sinus infection, also known as sinusitis or rhinosinusitis, occurs when your nasal ...
A pimple-like bump or sore inside the nose can sometimes be due to nasal vestibulitis or nasal folliculitis. It is a bacterial infection that can develop when hair follicles become infected ...
Sinusitis, or a sinus infection, can cause a stuffy or runny nose, a decreased sense of smell, and other symptoms. You can usually manage the symptoms at home with a decongestant. The sinuses are ...
The Immigration and Refugee Protection Act (IRPA) of 2002 provides the legislative authority for Canada’s immigration program. IRPA contains various provisions that allow the Minister to issue special ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
they are likely to miss some of the important instructions to be announced in the examination rooms/ halls. The NTA will not be responsible for any delay of the candidate to reach the examination ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果